血液系统疾病患者置入中心静脉导管发生血栓相关危险因素的Meta分析

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (2781 KB)
输出: BibTeX | EndNote (RIS)

摘要目的分析血液系统疾病患者经外周静脉穿刺置入中心静脉导管相关血栓(PICC-RT)形成的独立风险因素。方法使用计算机系统对PubMed、Web of Science、Medline、中国知网、维普及万方等数据库进行主题词检索,搜集血液系统患者置入 PICC 导管相关血栓的病例对照研究。检索时间设置为建库至2022年6月,通过2名研究员分别独立对检索到的血液系统患者PICC-RT影响因素的文献进行筛选,评估文献质量并提取相关数据。对提取的数据采用Revman5.3 软件进行Meta 分析,以筛选出血液系统患者PICC-RT的危险因素。结果共纳入14篇文献,涉及3127例患者,分析了38项影响因素,根据是否发生PICC-RT将患者分为研究组(n=297)和对照组(n=2830)。根据Meta及统计分析结果,将OR≥1且P≤0.05的10项影响因素列为血液系统患者PICC-RT危险因素:年龄≥60岁、合并感染、危险度分层为中高危、BMI≥25、ECOG评分≥2分、既往手术史、PICC导管尖端位置异常、非隧道式PICC、血小板水平≥350×10⁹/L、置管时间≥6个月。结论共发现10项血液系统患者PICC-RT的影响因素,可有助于血栓预防及疾病的风险分层。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	杨亚坤
	宋燕
	赵金娜
	刘娟
	许凤锐
	吕攀攀

关键词 ：血液疾病, 血栓, 经外周静脉穿刺置入中心静脉, 高危因素, 荟萃分析

Abstract：Objective To evaluate independent risk factors for peripherally inserted central catheter-related thrombosis (PICC-RT).Methods Literature search of the PubMed, Web of Science, Medline, China National Knowledge Infrastructure, VIP Chinese Science and Technology Periodicals, and Wanfang databases was performed for case control studies investigating patients who experienced PICC-RT, published from database inception to June 2022. Subsequently, two investigators independently screened the retrieved studies for factors influencing PICC-RT according to pre-defined admission and discharge criteria, and evaluated study quality and extracted the relevant data. Review Manager version 5.3 (The Cochrane Collaboration, 2020) was used to perform Meta-analysis on the extracted data to determine risk factors for PICC-RT.Results A total of 14 literatures were included, involving 3127 patients, and 38 influencing factors were analyzed. Patients were divided into study group (n=297) and control group (n=2830) according to whether PICC-RT occurred. According to the results of Meta and statistical analysis, 10 influencing factors with OR≥1 and P≤0.05 were listed as the risk factors for PICC-RT in patients with blood system: age ≥60 years, coinfection, risk stratification as medium-high risk, BMI≥25, ECOG score ≥2, previous surgical history, abnormal PICC catheter tip position, non-tunneling PICC, and platelet level ≥350×10⁹/L, and catheterization time >6 months.Conclusions A total of 10 factors influencing PICC-RT in hematological patients have been found, which may contribute to thrombosis prevention and disease risk stratification.

Key words： blood disease thrombosis peripherally inserted central catheter high risk factors Meta analysis

收稿日期: 2023-02-14

ZTFLH:

R552.1

基金资助:首都卫生发展科研专项自主创新基金 (2022-2-5111)

通讯作者: 吕攀攀,E-mail:lvpanpan307@163.com

作者简介: 杨亚坤,本科学历, 主管护师。

引用本文:

杨亚坤, 宋燕, 赵金娜, 刘娟, 许凤锐, 吕攀攀. 血液系统疾病患者置入中心静脉导管发生血栓相关危险因素的Meta分析[J]. 武警医学, 2023, 34(9): 799-804. YANG Yakun, SONG Yan, ZHAO Jinna, LIU Juan, XU Fengrui, LV Panpan. Meta analysis of risk factors for thrombosis in patients with hematological diseases receiving central venous catheter via peripheral vein puncture. Med. J. Chin. Peop. Armed Poli. Forc., 2023, 34(9): 799-804.

链接本文:

http://journal08.magtechjournal.com/Jwk_wjyx/CN/ 或 http://journal08.magtechjournal.com/Jwk_wjyx/CN/Y2023/V34/I9/799

[1]	Gillian R Barruel,Formal A,Methodology,et al. Barriers and facilitators for implementing peripherally inserted central catheter (PICC) appropriateness guidelines: a longitudinal survey study from 34 Michigan hospitals[J]. PLoS One,2022,17(11): e0277302.
[2]	Yan H,Yun L,Yingying Y,et al. Analysis of risk factors of PICC-related bloodstream infection in newborns: implications for nursing care[J]. Eur J Med Res,2021,26:80.
[3]	Sona D, Qinghua Z, Birendra S B. Peripherally inserted central catheters in critically ill patients-complications and its prevention: a review[J]. Int J Nurs Sci,2019,6(1):99105.
[4]	Osamah A, Manar A, Hany E. Predictive risk factors of venous thromboembolism (VTE) associated with peripherally inserted central catheters (PICC) in ambulant solid cancer patients: retrospective single Centre cohort study [J].Thromb J,2019,17(1): 2.
[5]	Lokich J J, Becker B.Subclavian vein thrombosis in patients treated with infusion chemotherapy for advanced malignancy[J]. Cancer,1983,52:1586-1589.
[6]	Xiaomin S,Hong L,Fang C, et al. A longitudinal observational retrospective study on risk factors and predictive model of PICC associated thrombosis in cancer patients[J]. Sci Rep,2020,10:10090.
[7]	Young M A, Begum G, Billingham J L, et al. A multicentre prospective randomized controlled trial (RCT) of thrombosis prophylaxis with warfarin in cancer patients with central venous catheters (CVCs) [J]. Proc Am Soc Clin Oncol, 2005,23:8004a.
[8]	Mark J L,Bradley S S, Shelby M H, et al. What are the risk factors for an upper extremity deep venous thrombosis after orthopaedic irrigation and debridement and peripherally inserted central catheter placement?[J]. Mo Med,2021,118(4):374-380.
[9]	Yajuan L,Yong H,Bo P,et al. Risk associated with central catheters for malignant tumor patients: a systematic review and meta-analysis[J].Oncotarget,2018,9(15): 12376-12388.
[10]	魏沄沄,张元元.儿童急性淋巴细胞白血病诱导化疗期导管相关性血栓发病及危险因素分析[J]. 中华血液学杂志,2017,38(4):313-317.
[11]	王枫,孙建,谢辉.急性白血病PICC置管后静脉血栓发生的回顾性分析[J].现代肿瘤医学,2014,22(11):2686-2688.
[12]	沈晶晶. 急性白血病化疗患者PICC相关性血栓影响因素分析及干预措施[J]. 全科医学临床与教育,2020,18(2):173-175.
[13]	徐咏梅,胡桑,程凤,等. 血液肿瘤患者 PICC 置管后并发静脉血栓的原因分析[J].安徽医学,2018,39(9):1146-1148.
[14]	钱玲玲. 恶性血液病导管相关性血栓的回顾性研究[D].南京:南京医科大学,2017.
[15]	郑彩凤. 血液肿瘤患者PICC导管相关静脉血栓的危险因素及预防措施研究[D].广州:广东医科大学,2018.
[16]	刘艳慧,张茵. 血液肿瘤患者PICC相关性静脉血栓临床分析[J]. 血栓与止血,2016,22(4):433-435.
[17]	黎建云,涂传清,彭玲,等. 急性白血病患者经外周静脉穿刺置入中心静脉导管致静脉血栓形成的研究[J].血栓与止血学,2017,23(2):214-217.
[18]	Hong Q, Jin L, Chunyan X,et al. Predisposing factors and effect of bundle nursing in PICC-related upper extremity deep venous thrombosis in patients with non-Hodgkin's lymphoma undergoing chemotherapy[J]. Am J Transl Res, 2021,13(8):9679-9686.
[19]	Priya S, Katharine W, David C,et al. Retrospective cohort analysis comparing the incidence of deep vein thromboses between peripherally-inserted and long-term skin tunneled venous catheters in hemato-oncology patients[J]. Thromb J, 2015,13:21.
[20]	Salvatore G M, Roberto L, Corrado G,et al. Catheter-associated bloodstream infections and thrombotic risk in hematologic patients with peripherally inserted central catheters (PICC)[J].Support Care Cancer, DOI 10.1007/s00520-015-2740-7.
[21]	Agostino C, Marco M, Anna F, et al. Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study[J]. Br J Haematol,2005,129(129): 811-817.
[22]	Tetsuaki B, Shin F, Rui M,et al. Risk factors for complications associated with peripherally inserted central catheters during induction chemotherapy for acute myeloid leukemia[J]. Intern Med, 2022,61:989-995.
[23]	梁梅菊,张兰兰,葛朋莉. 白血病患者接受PICC置管后DVT发生因素Logistic分析及应用风险管理干预措施的效果研究[J].全科护理 ,2020,8(1): 52-55
[24]	Vineet C, Megan O M, Jennifer H, et al. Improving peripherally inserted central catheter appropriateness and reducing device-related complications: a quasiexperimental study in 52 Michigan hospitals[J]. BMJ Qual Saf,2022 ,31(1):23-30.
[25]	中国临床肿瘤学会肿瘤与血栓专家共识委员会. 肿瘤相关静脉血栓栓塞症预防与治疗指南(2019版) [J].中国实用内科杂志,2019,46(13):653-660.
[26]	Donati M B. Thrombosis and cancer: 40 years of research[J].Thromb Res,2012, 129(3):348-352.
[27]	Leung T K,Lee C M, Tai C J, et al .Aretrospective study on the long-term placement of peripherally inserted central catheter sand the importance of nursing care and education[J] .Cancer nursing,2011,34(1): E25-E30.
[28]	Xinyu Y, Xiaoye C. The role of type 1 interferons in coagulation induced by gram-negative bacteria[J].Blood,2020,14(135):1087-1100.
[29]	Lobo B L,Vaidean G,Broyles J,et al.Risk of venous throomboembolism in hospitalized patients with peripherally inserted central catheters[J]. J Hosp Med,2009,4(7):417-422.
[30]	Gholamreza B,Pourya S,Ali M A, et al. A review of peripherally inserted central catheters and various types of vascular access in very small children and pediatric patients and their potential complications [J]. J Med Life,2021,14(3): 298-309.
[31]	Marina A T, María A. Rodríguez P,et al. Tunneled catheter-related bacteremia in hemodialysis patients: incidence, risk factors and outcomes. a 14-year observational study[J]. J Nephrol,2023,36(1):203-212.